Founded in 2016 and headquarter in Palo Alto, California, Immune-Onc is a biopharmaceutical company dedicated to the development of innovative tumour antibody drugs for cancer. The company combines cutting-edge international research results with professional drug development capabilities to accelerate the progress of tumor immunotherapy drugs and bring new treatment options to cancer patients.